KM Research Hub
← 返回论文库
已完成 入排:排除 图源:可得 入排置信度 0.96

Impact of age and sex on the efficacy and safety of ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy: a subgroup analysis of the ARMANI phase III trial.

R Fazio, G Randon, F Bergamo, F Palermo, S Tamberi, E Giommoni, S Di Donato, L Fornaro, O Brunetti, F De Vita, M Valgiusti, S M Gobba, A Spallanzani, S Murgioni, V Bethaz, A Strippoli, T P Latiano, G G Cardellino, C Ceccon, A Raimondi, M Prisciandaro, C C Pircher, M Ambrosini, P Manca, M Fassan, M Di Bartolomeo, M Di Maio, F Pietrantonio

ESMO Open 10(7) 105329

PMID40540760
PMCIDPMC12221353
DOI10.1016/j.esmoop.2025.105329
发表日期2025-06-20
入排依据:属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。
摘要

摘要

BACKGROUND: There is a growing interest in optimizing the therapeutic management of older cancer patients as well as understanding the sex-specific differences in terms of efficacy and safety of cancer treatments. However, limited data are available on the initial therapy of patients with advanced gastro-oesophageal cancer. MATERIALS AND METHODS: The ARMANI phase III trial showed progression-free survival (PFS) and overall survival (OS) benefit with paclitaxel plus ramucirumab switch maintenance (arm A) versus the continuation of first-line oxaliplatin and fluoropyrimidine (arm B) in patients with advanced human epidermal growth factor receptor 2-negative gastric or gastro-oesophageal junction cancer. We conducted a subgroup analysis aimed at assessing the differences in efficacy, safety and quality of life (QoL) according to age (<70 versus ≥70 years) and sex. RESULTS: No significant differences in terms of PFS (P = 0.757), OS (P = 0.588) and overall response rates (ORRs) (P = 0.238) were observed between older and younger patients. No significant differences in PFS (P = 0.646), OS (P = 0.858) and ORRs (P = 0.649) were observed between females and males. The effect of treatment arm on survival outcomes was similar across age (P = 0.094) and sex groups (P = 0.469). Looking at specific adverse events, peripheral neuropathy occurred more frequently in younger patients (P = 0.020), anaemia in older patients (P = 0.044) and hand-foot syndrome in women (P = 0.021). Older patients were less likely to receive a post-discontinuation treatment (P = 0.010), especially in arm B (P = 0.026). The impact on QoL was better in arm A, irrespective of age and sex. CONCLUSION: The ARMANI trial supported the benefit of the investigated switch maintenance strategy irrespective of age and sex.

KM 提取结果

2 个 Figure · 8 个 KM 面板

进入结果中心
KM Figure4 个面板

Figure 1

Figure 1 Survival analysis according to age . Kaplan–Meier curves for progression-free survival (PFS) and overall survival (OS) in patients stratified according to (A, B) age (<70 and ≥70 years) and (C, D) age and treatment arm (<70 years arm A, <70 years arm B, ≥70 years arm A and ≥70 years arm B). CI, confidence interval; HR, hazard ratio.

A

PFS

Figure 1 · Panel A

complete 待 EXE 对齐 预期 2 条 已提取 2 条

Panel A 是同一 Figure 1 中的独立 KM 子图;人群、终点或分析条件以本 Panel 图注语义为准。

查看结果
B

OS

Figure 1 · Panel B

complete 待 EXE 对齐 预期 2 条 已提取 2 条

Panel B 是同一 Figure 1 中的独立 KM 子图;人群、终点或分析条件以本 Panel 图注语义为准。

查看结果
C

PFS

Figure 1 · Panel C

complete 待 EXE 对齐 预期 4 条 已提取 4 条

Panel C 是同一 Figure 1 中的独立 KM 子图;人群、终点或分析条件以本 Panel 图注语义为准。

查看结果
D

OS

Figure 1 · Panel D

quality_warning 待 EXE 对齐 预期 4 条 已提取 3 条

Panel D 是同一 Figure 1 中的独立 KM 子图;人群、终点或分析条件以本 Panel 图注语义为准。

质量提示疑似重复轨迹:同一条 KM 曲线可能被重复识别疑似图例或人工水平线:轨迹出现不合理的共同平台曲线缺失:预期 4 条,实际恢复 3 条疑似重复轨迹:同一条 KM 曲线可能被重复识别
查看结果
KM Figure4 个面板

Figure 2

Figure 2 Survival analysis according to sex . Kaplan–Meier curves for progression-free survival (PFS) and overall survival (OS) in patients stratified according to (A, B) sex (female and male) and (C, D) sex and treatment arm (female arm A, female arm B, male arm A and male arm B). CI, confidence interval; HR, hazard ratio.

A

PFS

Figure 2 · Panel A

quality_warning 待 EXE 对齐 预期 2 条 已提取 1 条

Panel A 是同一 Figure 2 中的独立 KM 子图;人群、终点或分析条件以本 Panel 图注语义为准。

质量提示疑似重复轨迹:同一条 KM 曲线可能被重复识别曲线缺失:预期 2 条,实际恢复 1 条疑似重复轨迹:同一条 KM 曲线可能被重复识别
查看结果
B

OS

Figure 2 · Panel B

complete 待 EXE 对齐 预期 2 条 已提取 2 条

Panel B 是同一 Figure 2 中的独立 KM 子图;人群、终点或分析条件以本 Panel 图注语义为准。

查看结果
C

PFS

Figure 2 · Panel C

complete 待 EXE 对齐 预期 4 条 已提取 4 条

Panel C 是同一 Figure 2 中的独立 KM 子图;人群、终点或分析条件以本 Panel 图注语义为准。

查看结果
D

OS

Figure 2 · Panel D

complete 待 EXE 对齐 预期 4 条 已提取 4 条

Panel D 是同一 Figure 2 中的独立 KM 子图;人群、终点或分析条件以本 Panel 图注语义为准。

查看结果
其他 Figure(1,默认折叠)

这些图片未产生 KM 曲线结果,不在主页面重复展示。

Figure 3Figure 3 Quality of life analysis according to age and sex. Mean changes in global quality of life from baseline according to age (A) and sex (B) .
非 KM Figure